BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 19, Issue 41
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (15637)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.
Item 
Count 
PDF951
HTML11340
Figures (1-2)542
Tables (1-1)303
 Sum=13136
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1548
Download953
 Sum=2501
Nov 7, 2013 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Dongiovanni P, Donati B, Fares R, Lombardi R, Mancina RM, Romeo S, Valenti L. PNPLA3 I148M polymorphism and progressive liver disease. World J Gastroenterol 2013; 19(41): 6969-6978 [PMID: 24222941 DOI: 10.3748/wjg.v19.i41.6969]
URL: https://www.wjgnet.com/1007-9327/full/v19/i41/6969.htm
Number Citing Articles
1
Eleonora Scorletti, Rotonya M. Carr. A new perspective on NAFLD: Focusing on lipid droplets. Journal of Hepatology 2022; 76(4): 934 doi: 10.1016/j.jhep.2021.11.009
2
Haiying Zhang, Li Xue, Lizhen Chen, Shunshun Jiang, Yongning Xin, Shiying Xuan. A Meta-Analysis of the Association Between the I148M Variant of Patatin-Like Phospholipase Domain Containing 3 Gene and the Presence of Chronic Hepatitis C. Hepatitis Monthly 2015; 15(11) doi: 10.5812/hepatmon.31987
3
Reem Al-Qarni, Muhammad Iqbal, Maram Al-Otaibi, Faisal Al-Saif, Assim A. Alfadda, Hisham Alkhalidi, Fahad Bamehriz, Mazen Hassanain. Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease. Medicine 2020; 99(36): e21463 doi: 10.1097/MD.0000000000021463
4
Maral Amangurbanova, Daniel Q. Huang, Rohit Loomba. Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLD. Alimentary Pharmacology & Therapeutics 2023; 57(1): 37 doi: 10.1111/apt.17292
5
Samantha G. Tilson, Carola M. Morell, An‐Sofie Lenaerts, Seung Bum Park, Zongyi Hu, Benjamin Jenkins, Albert Koulman, T. Jake Liang, Ludovic Vallier. Modeling PNPLA3‐Associated NAFLD Using Human‐Induced Pluripotent Stem Cells. Hepatology 2021; 74(6): 2998 doi: 10.1002/hep.32063
6
Raffaela Rametta, Massimiliano Ruscica, Paola Dongiovanni, Chiara Macchi, Anna L. Fracanzani, Liliana Steffani, Silvia Fargion, Paolo Magni, Luca Valenti. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin‐A independently of insulin resistance. European Journal of Clinical Investigation 2014; 44(7): 627 doi: 10.1111/eci.12280
7
Zongsheng Huang, Xianwen Guo, Guo Zhang, Liexin Liang, Bing Nong. Correlation between PNPLA3 rs738409 polymorphism and hepatocellular carcinoma: a meta-analysis of 10,330 subjects. The International Journal of Biological Markers 2019; 34(2): 117 doi: 10.1177/1724600818812471
8
Piero Pingitore, Paola Dongiovanni, Benedetta Maria Motta, Marica Meroni, Saverio Massimo Lepore, Rosellina Margherita Mancina, Serena Pelusi, Cristina Russo, Andrea Caddeo, Giorgio Rossi, Tiziana Montalcini, Arturo Pujia, Olov Wiklund, Luca Valenti, Stefano Romeo. PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis. Human Molecular Genetics 2016; : ddw341 doi: 10.1093/hmg/ddw341
9
Jian-Hua Shen, Yi-Ling Li, Dan Li, Ning-Ning Wang, Lei Jing, Yu-Hong Huang. The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta-analysis. Journal of Lipid Research 2015; 56(1): 167 doi: 10.1194/jlr.M048777
10
Anita Arslanow, Caroline S. Stokes, Susanne N. Weber, Frank Grünhage, Frank Lammert, Marcin Krawczyk. The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP). Liver International 2016; 36(3): 418 doi: 10.1111/liv.12937
11
Yen‐Po Lin, Yu‐Chieh Tsai, Mu Jung Tsai, Pao‐Yuan Huang, Chien‐Hung Chen, Chih‐Chien Yao, Seng‐Kee Chuah, Yuan‐Hung Kuo, Wei‐Chen Tai, Wei‐Shiung Lian, Hsin‐Wei Fang, Tsung‐Hui Hu, Ming‐Chao Tsai. Effect of gut microbiota and PNPLA3 polymorphisms on nonalcoholic fatty liver disease in lean and obese individuals. Advances in Digestive Medicine 2024; 11(3): 129 doi: 10.1002/aid2.13367
12
Luigi Boccuto, Ludovico Abenavoli, Lauren Cascio, Sujata Srikanth, Barbara DuPont, Andrew R. Mitz, Roger Curtis Rogers, Katy Phelan. Variability in Phelan‐McDermid syndrome: The impact of the PNPLA3 p.I148M polymorphism. Clinical Genetics 2018; 94(6): 590 doi: 10.1111/cge.13451
13
Stefano Romeo, Luca Valenti. Regulation of retinol‐binding protein 4 and retinol metabolism in fatty liver disease. Hepatology 2016; 64(5): 1414 doi: 10.1002/hep.28722
14
Roberta Fares, Salvatore Petta, Rosa Lombardi, Stefania Grimaudo, Paola Dongiovanni, Rosaria Pipitone, Raffaela Rametta, Anna Ludovica Fracanzani, Enrico Mozzi, Antonio Craxì, Silvia Fargion, Giorgio Sesti, Luca Valenti. The UCP2 ‐866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.. Liver International 2015; 35(5): 1574 doi: 10.1111/liv.12707
15
Kentaro Oniki, Junji Saruwatari, Tomoko Izuka, Ayami Kajiwara, Kazunori Morita, Misaki Sakata, Koji Otake, Yasuhiro Ogata, Kazuko Nakagawa, Silvia C. Sookoian. Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects. PLOS ONE 2015; 10(7): e0132640 doi: 10.1371/journal.pone.0132640
16
Ines Volkert, Malin Fromme, Carolin Schneider, Lena Candels, Cecilia Lindhauer, Huan Su, Katrine Thorhauge, Monica Pons, Mohamed Ramadan Mohamed, Kai Markus Schneider, Pavel Strnad, Christian Trautwein. Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression. Hepatology 2024; 79(4): 898 doi: 10.1097/HEP.0000000000000574
17
R.B. Prussick, L. Miele. Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?. British Journal of Dermatology 2018; 179(1): 16 doi: 10.1111/bjd.16239
18
Vittoria Manilla, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani. Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to Cancer. Nutrients 2023; 15(11): 2521 doi: 10.3390/nu15112521
19
Guido Alessandro Baselli, Paola Dongiovanni, Raffaela Rametta, Marica Meroni, Serena Pelusi, Marco Maggioni, Sara Badiali, Piero Pingitore, Samantha Maurotti, Tiziana Montalcini, Alice Emma Taliento, Daniele Prati, Giorgio Rossi, Anna Ludovica Fracanzani, Rosellina Margherita Mancina, Stefano Romeo, Luca Valenti. Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker. Gut 2020; 69(10): 1855 doi: 10.1136/gutjnl-2019-319226
20
Mohammed Eslam, Luca Valenti, Stefano Romeo. Genetics and epigenetics of NAFLD and NASH: Clinical impact. Journal of Hepatology 2018; 68(2): 268 doi: 10.1016/j.jhep.2017.09.003
21
Nina L. Gluchowski, Michel Becuwe, Tobias C. Walther, Robert V. Farese. Lipid droplets and liver disease: from basic biology to clinical implications. Nature Reviews Gastroenterology & Hepatology 2017; 14(6): 343 doi: 10.1038/nrgastro.2017.32
22
Anna Viitasalo, Mustafa Atalay, Jussi Pihlajamäki, Jarmo Jääskeläinen, Ayhan Korkmaz, Dorota Kaminska, Virpi Lindi, Timo A. Lakka. The 148 M allele of the PNPLA3 is associated with plasma irisin levels in a population sample of Caucasian children: The PANIC Study. Metabolism 2015; 64(7): 793 doi: 10.1016/j.metabol.2015.01.010
23
Alessandro Mantovani, Stefano Ballestri, Amedeo Lonardo, Giovanni Targher. Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2016; 61(5): 1246 doi: 10.1007/s10620-016-4040-6
24
Marina Kawaguchi-Suzuki, Kenneth Cusi, Fernando Bril, Yan Gong, Taimour Langaee, Reginald F. Frye. A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00752
25
Marcin Krawczyk, Raúl Jiménez-Agüero, José M. Alustiza, José I. Emparanza, María J. Perugorria, Luis Bujanda, Frank Lammert, Jesús M. Banales. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery. Surgery for Obesity and Related Diseases 2016; 12(10): 1838 doi: 10.1016/j.soard.2016.06.004
26
Rosa Lombardi, Salvatore Petta, Giuseppina Pisano, Paola Dongiovanni, Luca Rinaldi, Luigi Elio Adinolfi, Carlo Acierno, Luca Valenti, Roberta Boemi, Federica Spatola, Antonio Craxì, Silvia Fargion, Anna Ludovica Fracanzani. FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage. Clinical Gastroenterology and Hepatology 2020; 18(2): 517 doi: 10.1016/j.cgh.2018.11.011
27
Yongqiang Ma, Guangshun Chen, Junfang Yi, Qiang Li, Zhi Tan, Wenling Fan, Xiaohua Luo, Zhiyong He, Zhongzhou Si, Jiequn Li. IRX3 plays an important role in the pathogenesis of metabolic-associated fatty liver disease by regulating hepatic lipid metabolism. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.895593
28
Cristiana Bianco, Elia Casirati, Francesco Malvestiti, Luca Valenti. Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets. JHEP Reports 2021; 3(3): 100284 doi: 10.1016/j.jhepr.2021.100284
29
Nathan L Meyers, Krystal A Fontaine, G Renuka Kumar, Melanie Ott. Entangled in a membranous web: ER and lipid droplet reorganization during hepatitis C virus infection. Current Opinion in Cell Biology 2016; 41: 117 doi: 10.1016/j.ceb.2016.05.003
30
Marica Meroni, Miriam Longo, Giada Tria, Paola Dongiovanni. Genetics Is of the Essence to Face NAFLD. Biomedicines 2021; 9(10): 1359 doi: 10.3390/biomedicines9101359
31
Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Parmjeet Randhawa, Eizaburo Sasatomi. Transplantation of the Liver. 2015; : 1112 doi: 10.1016/B978-1-4557-0268-8.00084-1
32
Na Li, Xiaodan Li, Yifu Ding, Xiao Liu, Karin Diggle, Tatiana Kisseleva, David A. Brenner. SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies. Biomedicines 2023; 11(12): 3280 doi: 10.3390/biomedicines11123280
33
Maria A. Burza, Rocco Spagnuolo, Tiziana Montalcini, Patrizia Doldo, Arturo Pujia, Stefano Romeo. Effect of Excess Body Weight on the Genetic Susceptibility to Cancer. Journal of Clinical Gastroenterology 2014; 48(Supplement 1): S78 doi: 10.1097/MCG.0000000000000237
34
Hiroyasu Sakai, Yohei Shirakami, Masahito Shimizu. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. World Journal of Gastroenterology 2016; 22(1): 394-406 doi: 10.3748/wjg.v22.i1.394
35
Rosa Lombardi, Silvia Fargion, Anna Ludovica Fracanzani. Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review. Digestive and Liver Disease 2019; 51(9): 1214 doi: 10.1016/j.dld.2019.05.015
36
Santiago Iturbe-Rey, Claudia Maccali, Marco Arrese, Patricia Aspichueta, Claudia P. Oliveira, Rui E. Castro, Ainhoa Lapitz, Laura Izquierdo-Sanchez, Luis Bujanda, Maria J. Perugorria, Jesus M. Banales, Pedro M. Rodrigues. Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD). Atherosclerosis 2025; 400: 119053 doi: 10.1016/j.atherosclerosis.2024.119053
37
Mengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, Dillon C. Gavlock, Richard DeBiasio, Gregory LaRocca, Celeste Reese, Rodrigo M. Florentino, Lanuza A. P. Faccioli, Jacquelyn A. Brown, Lawrence A. Vernetti, Mark Schurdak, Andrew M. Stern, Albert Gough, Jaideep Behari, Alejandro Soto-Gutierrez, D. Lansing Taylor, Mark T. Miedel. Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1423936
38
Omnia Aly, Hanan Hassan Zaki, Mohamed R. Herzalla, Ahmed Fathy, Nermin Raafat, Mohamed M. Hafez, Nadia M Hamdy. Gene polymorphisms of Patatin-like phospholipase domain containing 3 (PNPLA3), adiponectin, leptin in diabetic obese patients. PLOS ONE 2020; 15(6): e0234465 doi: 10.1371/journal.pone.0234465
39
Anna Viitasalo, Jussi Pihlajamäki, Jussi Paananen, Mustafa Atalay, Virpi Lindi, Timo A Lakka. Associations of TM6SF2 167K allele with liver enzymes and lipid profile in children: the PANIC Study. Pediatric Research 2016; 79(5): 684 doi: 10.1038/pr.2016.3
40
Anna Di Sessa, Giuseppina Rosaria Umano, Grazia Cirillo, Angela Del Prete, Roberta Iacomino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice. The Membrane‐bound O‐Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease. Journal of Pediatric Gastroenterology and Nutrition 2018; 67(1): 69 doi: 10.1097/MPG.0000000000001979
41
Edgar A. Villavicencio, Adriana Maldonado, Rebecca M. Crocker, Yue Guan, Chris Stallman, David O. Garcia. Communicating PNPLA3 genetic risk status for NAFLD among Mexican-origin men. Frontiers in Public Health 2023; 10 doi: 10.3389/fpubh.2022.1090101
42
Sven M. Francque. Towards precision medicine in non-alcoholic fatty liver disease. Reviews in Endocrine and Metabolic Disorders 2023; 24(5): 885 doi: 10.1007/s11154-023-09820-6
43
Xiao Yang, Frank J. Gonzalez, Min Huang, Huichang Bi. Nuclear receptors and non-alcoholic fatty liver disease: An update. Liver Research 2020; 4(2): 88 doi: 10.1016/j.livres.2020.03.001
44
Wenke Jonas, Annette Schürmann. Genetic and epigenetic factors determining NAFLD risk. Molecular Metabolism 2021; 50: 101111 doi: 10.1016/j.molmet.2020.101111
45
Valerio Nobili, Anna Alisi, Luca Valenti, Luca Miele, Ariel E. Feldstein, Naim Alkhouri. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nature Reviews Gastroenterology & Hepatology 2019; 16(9): 517 doi: 10.1038/s41575-019-0169-z
46
Cheng Peng, Alastair G. Stewart, Owen L. Woodman, Rebecca H. Ritchie, Cheng Xue Qin. Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.603926
47
Dina S. Ata, Mohy A.E. Awad, Manal A.E. Eid, Khaled I. ElShafey, Ola A. Taha. PNPLA3/adiponutrin I148M gene variant in nonalcoholic fatty liver disease in Egyptian children and adolescents. Alexandria Journal of Pediatrics 2021; 34(3): 203 doi: 10.4103/1687-9945.337830
48
Miriam Longo, Erika Paolini, Marica Meroni, Paola Dongiovanni. Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC. International Journal of Molecular Sciences 2021; 22(8): 4173 doi: 10.3390/ijms22084173
49
Mark A. Febbraio, Saskia Reibe, Shabnam Shalapour, Geraldine J. Ooi, Matthew J. Watt, Michael Karin. Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?. Cell Metabolism 2019; 29(1): 18 doi: 10.1016/j.cmet.2018.10.012
50
Dilum Ekanayake, Clinton Roddick, Lawrie W. Powell. Recent advances in hemochromatosis: a 2015 update. Hepatology International 2015; 9(2): 174 doi: 10.1007/s12072-015-9608-2
51
O. V. Smirnova, O. L. Moskalenko, E. V. Kasparov, I. E. Kasparova. Genetic predictors and pathophysiological features of non-alcoholic fat liver disease. Meditsinskiy sovet = Medical Council 2021; (15): 78 doi: 10.21518/2079-701X-2021-15-78-87
52
Verena Wieser, Timon E. Adolph, Barbara Enrich, Patrizia Moser, Alexander R. Moschen, Herbert Tilg. Weight loss induced by bariatric surgery restores adipose tissue PNPLA3 expression. Liver International 2017; 37(2): 299 doi: 10.1111/liv.13222
53
Sofía Montemayor, Silvia García, Margalida Monserrat-Mesquida, Josep A. Tur, Cristina Bouzas. Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review. Nutrients 2023; 15(18): 3987 doi: 10.3390/nu15183987
54
Tsunehiro Ochi, Kensuke Munekage, Masafumi Ono, Takuma Higuchi, Masayuki Tsuda, Yoshihiro Hayashi, Nobuto Okamoto, Katsumi Toda, Shuji Sakamoto, Jude A. Oben, Toshiji Saibara. Patatin-like phospholipase domain-containing protein 3 is involved in hepatic fatty acid and triglyceride metabolism through X-box binding protein 1 and modulation of endoplasmic reticulum stress in mice. Hepatology Research 2016; 46(6): 584 doi: 10.1111/hepr.12587
55
Emmi Suomela, Mervi Oikonen, Niina Pitkänen, Ari Ahola-Olli, Johanna Virtanen, Riitta Parkkola, Eero Jokinen, Tomi Laitinen, Nina Hutri-Kähönen, Mika Kähönen, Terho Lehtimäki, Leena Taittonen, Päivi Tossavainen, Antti Jula, Britt-Marie Loo, Vera Mikkilä, Risto Telama, Jorma S.A. Viikari, Markus Juonala, Olli T. Raitakari. Childhood predictors of adult fatty liver. The Cardiovascular Risk in Young Finns Study. Journal of Hepatology 2016; 65(4): 784 doi: 10.1016/j.jhep.2016.05.020
56
Alessandra Caligiuri, Alessandra Gentilini, Fabio Marra. Molecular Pathogenesis of NASH. International Journal of Molecular Sciences 2016; 17(9): 1575 doi: 10.3390/ijms17091575
57
Alexander J. Kovalic, Pratik Banerjee, Quynh T. Tran, Ashwani K. Singal, Sanjaya K. Satapathy. Genetic and Epigenetic Culprits in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology 2018; 8(4): 390 doi: 10.1016/j.jceh.2018.04.001
58
Huan Su, Madhuri Haque, Svea Becker, Karolina Edlund, Julia Duda, Qingbi Wang, Johanna Reißing, Hanns‐Ulrich Marschall, Lena S. Candels, Mohamed Mohamed, Wilhelm Sjöland, Lijun Liao, Stephan A. Drexler, Till Strowig, Jörg Rahnenführer, Jan G. Hengstler, Maximilian Hatting, Christian Trautwein. Long‐term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals. Liver International 2023; 43(8): 1699 doi: 10.1111/liv.15587
59
Elias Björnson, Bani Mukhopadhyay, Anna Asplund, Nusa Pristovsek, Resat Cinar, Stefano Romeo, Mathias Uhlen, George Kunos, Jens Nielsen, Adil Mardinoglu. Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization. Cell Reports 2015; 13(9): 2014 doi: 10.1016/j.celrep.2015.10.045
60
Stella De Nicola, Paola Dongiovanni, Alessio Aghemo, Cristina Cheroni, Roberta D'Ambrosio, Michele Pedrazzini, Francesco Marabita, Lorena Donnici, Marco Maggioni, Silvia Fargion, Massimo Colombo, Raffaele De Francesco, Luca Valenti, Matias A. Avila. Interaction between PNPLA3 I148M Variant and Age at Infection in Determining Fibrosis Progression in Chronic Hepatitis C. PLoS ONE 2014; 9(8): e106022 doi: 10.1371/journal.pone.0106022
61
Ahmad Al-Mrabeh, Sviatlana V. Zhyzhneuskaya, Carl Peters, Alison C. Barnes, Shaden Melhem, Aaron Jesuthasan, Benjamin Aribisala, Kieren G. Hollingsworth, Georg Lietz, John C. Mathers, Naveed Sattar, Michael E.J. Lean, Roy Taylor. Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss. Cell Metabolism 2020; 31(2): 233 doi: 10.1016/j.cmet.2019.11.018
62
R. Liebe, F. Lammert, M. Krawczyk. Metabolism and Pathophysiology of Bariatric Surgery. 2017; : 389 doi: 10.1016/B978-0-12-804011-9.00051-0
63
Eric Trépo, Luca Valenti. Update on NAFLD genetics: From new variants to the clinic. Journal of Hepatology 2020; 72(6): 1196 doi: 10.1016/j.jhep.2020.02.020
64
Ahmad Al-Mrabeh. Pathogenesis and remission of type 2 diabetes: what has the twin cycle hypothesis taught us?. Cardiovascular Endocrinology & Metabolism 2020; 9(4): 132 doi: 10.1097/XCE.0000000000000201
65
Benedetta Donati, Paola Dongiovanni, Stefano Romeo, Marica Meroni, Misti McCain, Luca Miele, Salvatore Petta, Silvia Maier, Chiara Rosso, Laura De Luca, Ester Vanni, Stefania Grimaudo, Renato Romagnoli, Fabio Colli, Flaminia Ferri, Rosellina Margherita Mancina, Paula Iruzubieta, Antonio Craxi, Anna Ludovica Fracanzani, Antonio Grieco, Stefano Ginanni Corradini, Alessio Aghemo, Massimo Colombo, Giorgio Soardo, Elisabetta Bugianesi, Helen Reeves, Quentin M. Anstee, Silvia Fargion, Luca Valenti. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04991-0
66
Sunday Amos Onikanni, Bashir Lawal, Oluwafemi Shittu Bakare, Basiru Olaitan Ajiboye, Oluwafemi Adeleke Ojo, Abdullah Farasani, Saeed M Kabrah, Gaber El-Saber Batiha, Carlos Adam Conte-Junior. Cancer of the Liver and its Relationship with Diabetes mellitus. Technology in Cancer Research & Treatment 2022; 21 doi: 10.1177/15330338221119743
67
Ana Cecilia Pontoriero, Julieta Trinks, María Laura Hulaniuk, Mariela Caputo, Lisandro Fortuny, Leandro Burgos Pratx, Analía Frías, Oscar Torres, Félix Nuñez, Adrián Gadano, Pablo Argibay, Daniel Corach, Diego Flichman. Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populations. BMC Genetics 2015; 16(1) doi: 10.1186/s12863-015-0255-3
68
Amal M.H. Mackawy, Mohamed E.H. Badawi, Ola Megahed. Patatin-like phospholipase domain containing-3 gene (PNPLA3) I148M polymorphism and liver damage in chronic hepatitis C Egyptian patients. Egyptian Journal of Medical Human Genetics 2015; 16(4): 333 doi: 10.1016/j.ejmhg.2015.06.001
69
Rosa Lombardi, Alessandro Mantovani, Annalisa Cespiati, Paolo Francione, Gabriele Maffi, Elena Del Zanna, Claudio Maffeis, Antonio Colecchia, Nicola Passigato, Alberto Ferrarese, Caterina Daniela Cusumanu, Rosanna Villani, Emanuela Orsi, Valeria Grancini, Lorena Airaghi, Daniela Bignamini, Gaetano Serviddio, Giovanni Targher, Paola Dongiovanni, Silvia Fargion, Anna Ludovica Fracanzani. Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors. Digestive and Liver Disease 2024; 56(4): 551 doi: 10.1016/j.dld.2023.09.023
70
Agostino Di Ciaula, Leonilde Bonfrate, Marcin Krawczyk, Gema Frühbeck, Piero Portincasa. Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis. International Journal of Molecular Sciences 2022; 23(5): 2636 doi: 10.3390/ijms23052636
71
Yanfang Zhang, Tongsheng Guo, Funing Yang, Yuanli Mao, Liubing Li, Chenxi Liu, Qiang Sun, Yongzhe Li, Jing Huang. Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese males. Hepatology International 2018; 12(5): 429 doi: 10.1007/s12072-018-9889-3
72
Susanne Schuster, Daniel Cabrera, Marco Arrese, Ariel E. Feldstein. Triggering and resolution of inflammation in NASH. Nature Reviews Gastroenterology & Hepatology 2018; 15(6): 349 doi: 10.1038/s41575-018-0009-6
73
Paloma Sangro, Manuel de la Torre Aláez, Bruno Sangro, Delia D’Avola. Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment. Journal of Physiology and Biochemistry 2023; 79(4): 869 doi: 10.1007/s13105-023-00954-4
74
Yan Zhao, Wenli Zhao, Jingchao Ma, Maeda Toshiyoshi, Ye Zhao. Patatin-like phospholipase domain-containing 3 gene (PNPLA3) polymorphic (rs738409) single nucleotide polymorphisms and susceptibility to nonalcoholic fatty liver disease: A meta-analysis of twenty studies. Medicine 2023; 102(10): e33110 doi: 10.1097/MD.0000000000033110
75
Rosa Lombardi, Federica Iuculano, Giada Pallini, Silvia Fargion, Anna Ludovica Fracanzani. Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease. International Journal of Molecular Sciences 2020; 21(22): 8761 doi: 10.3390/ijms21228761
76
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto. Screening strategy for non-alcoholic fatty liver disease. Clinical and Molecular Hepatology 2023; 29(Suppl): S103 doi: 10.3350/cmh.2022.0336
77
Paola Dongiovanni, Erika Paolini, Alberto Corsini, Cesare R. Sirtori, Massimiliano Ruscica. Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches. European Journal of Clinical Investigation 2021; 51(7) doi: 10.1111/eci.13519
78
Amedeo Lonardo, Fabio Nascimbeni, Giovanni Targher, Mauro Bernardi, Ferruccio Bonino, Elisabetta Bugianesi, Alessandro Casini, Amalia Gastaldelli, Giulio Marchesini, Fabio Marra, Luca Miele, Filomena Morisco, Salvatore Petta, Fabio Piscaglia, Gianluca Svegliati-Baroni, Luca Valenti, Stefano Bellentani. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. Digestive and Liver Disease 2017; 49(5): 471 doi: 10.1016/j.dld.2017.01.147
79
Björn Carlsson, Daniel Lindén, Gabriella Brolén, Mathias Liljeblad, Mikael Bjursell, Stefano Romeo, Rohit Loomba. Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics 2020; 51(12): 1305 doi: 10.1111/apt.15738
80
Paola Dongiovanni, Luca Valenti. Genetics of nonalcoholic fatty liver disease. Metabolism 2016; 65(8): 1026 doi: 10.1016/j.metabol.2015.08.018
81
Cristina B. Guzman, Suman Duvvuru, Anthony Akkari, Pallav Bhatnagar, Chakib Battioui, Wendra Foster, Xiaotian Michelle Zhang, Sudha S. Shankar, Mark A. Deeg, Naga Chalasani, Thomas A. Hardy, Christof M. Kazda, Sreekumar G. Pillai. Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist. Hepatology Communications 2018; 2(5): 561 doi: 10.1002/hep4.1171
82
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism 2017; 71: 182 doi: 10.1016/j.metabol.2017.03.013
83
Onni Niemelä. Advances In Clinical Chemistry. Advances in Clinical Chemistry 2023; 116: 113 doi: 10.1016/bs.acc.2023.05.002
84
Jérôme Boursier, Anna Mae Diehl. Patatin‐like phospholipase domain‐containing protein 3 and Liver Disease: Opportunities to Unravel Mechanisms Underlying Statistical Associations. Hepatology 2015; 61(1): 18 doi: 10.1002/hep.27445
85
Paola Dongiovanni, Raffaela Rametta, Marica Meroni, Luca Valenti. The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development – a potential therapeutic target?. Expert Review of Gastroenterology & Hepatology 2016; 10(2): 229 doi: 10.1586/17474124.2016.1110018
86
Carmen Fierbinteanu-Braticevici, Crina Sinescu, Alexandru Moldoveanu, Ana Petrisor, Sorina Diaconu, Dragos Cretoiu, Bogdan Braticevici. Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health. Cell Biology and Toxicology 2017; 33(1): 5 doi: 10.1007/s10565-016-9361-x
87
Martijn R. Molenaar, Louis C. Penning, J. Bernd Helms. Playing Jekyll and Hyde—The Dual Role of Lipids in Fatty Liver Disease. Cells 2020; 9(10): 2244 doi: 10.3390/cells9102244
88
Marco Arrese, Juan P. Arab, Francisco Barrera, Benedikt Kaufmann, Luca Valenti, Ariel E. Feldstein. Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity. Seminars in Liver Disease 2021; 41(04): 421 doi: 10.1055/s-0041-1730927
89
Silvia Sookoian, Carlos J. Pirola, Luca Valenti, Nicholas O. Davidson. Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology. Hepatology 2020; 72(1): 330 doi: 10.1002/hep.31229
90
Sandra Steensels, Jixuan Qiao, Baran A. Ersoy. Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease. Metabolites 2020; 10(7): 283 doi: 10.3390/metabo10070283
91
Sylwia Ziolkowska, Agata Binienda, Maciej Jabłkowski, Janusz Szemraj, Piotr Czarny. The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(20): 11128 doi: 10.3390/ijms222011128
92
Sven Francque, Vlad Ratziu. Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2023; 27(2): 429 doi: 10.1016/j.cld.2023.01.010
93
Haofei Hu, Changchun Cao, Yong Han, Yongcheng He. Triglyceride affects the association between estimated glomerular filtration rate and the onset of non-alcoholic fatty liver disease: A second analysis of a Chinese cohort study. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.984241
94
Joseph L. Dempsey, George N. Ioannou, Rotonya M. Carr. Mechanisms of Lipid Droplet Accumulation in Steatotic Liver Diseases. Seminars in Liver Disease 2023; 43(04): 367 doi: 10.1055/a-2186-3557
95
Paola Dongiovanni, Salvatore Petta, Ville Mannisto, Rosellina Margherita Mancina, Rosaria Pipitone, Vesa Karja, Marco Maggioni, Pirjo Kakela, Olov Wiklund, Enrico Mozzi, Stefania Grimaudo, Dorota Kaminska, Raffaela Rametta, Antonio Craxi, Silvia Fargion, Valerio Nobili, Stefano Romeo, Jussi Pihlajamaki, Luca Valenti. Statin use and non-alcoholic steatohepatitis in at risk individuals. Journal of Hepatology 2015; 63(3): 705 doi: 10.1016/j.jhep.2015.05.006
96
Kh. A. Kurtanov, L. A. Sydykova, N. I. Pavlova, N. P. Filippova, V. V. Dodokhov, G. A. Apsolikhova, N. A. Solov'eva, A. T. D'yakonova, L. M. Neustroeva, M. A. Varlamova, N. V. Borisova. Polymorphism of the adiponutrin gene (PNPLA3) in the indigenous inhabitants of the Republic of Sakha (Yakutia) with type 2 diabetes mellitus. Almanac of Clinical Medicine 2018; 46(3): 258 doi: 10.18786/2072-0505-2018-46-3-258-263
97
Nwe Ni Than, Philip N. Newsome. A concise review of non-alcoholic fatty liver disease. Atherosclerosis 2015; 239(1): 192 doi: 10.1016/j.atherosclerosis.2015.01.001
98
Manoj Amrutkar, Urszula Chursa, Matthias Kern, Esther Nuñez‐Durán, Marcus Ståhlman, Silva Sütt, Jan Borén, Bengt R. Johansson, Hanns‐Ulrich Marschall, Matthias Blüher, Margit Mahlapuu. STK25 is a critical determinant in nonalcoholic steatohepatitis. The FASEB Journal 2016; 30(10): 3628 doi: 10.1096/fj.201600562R
99
A.‐J. Chamorro, J.‐L. Torres, J.‐A. Mirón‐Canelo, R. González‐Sarmiento, F.‐J. Laso, M. Marcos. Systematic review with meta‐analysis: the I148M variant of patatin‐like phospholipase domain‐containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosis. Alimentary Pharmacology & Therapeutics 2014; 40(6): 571 doi: 10.1111/apt.12890
100
Michael Zimmer, Pradeep Bista, Ericka L. Benson, Diana Y. Lee, Feng Liu, Dominic Picarella, Rick B. Vega, Chi B. Vu, Maisy Yeager, Min Ding, Guosheng Liang, Jay D. Horton, Robert Kleemann, Teake Kooistra, Martine C. Morrison, Peter Y. Wielinga, Jill C. Milne, Michael R. Jirousek, Andrew J. Nichols. CAT‐2003: A novel sterol regulatory element‐binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3‐Leiden mice. Hepatology Communications 2017; 1(4): 311 doi: 10.1002/hep4.1042
101
Ivica Grgurevic, Tonci Bozin, Mislav Mikus, Michal Kukla, James O’Beirne. Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach. Cancers 2021; 13(22): 5844 doi: 10.3390/cancers13225844
102
Matthew Kappus, Manal Abdelmalek. De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation. Clinics in Liver Disease 2017; 21(2): 321 doi: 10.1016/j.cld.2016.12.006
103
Martti Färkkilä, Hannu Kautiainen, Andrea Tenca, Kalle Jokelainen, Johanna Arola, Antonio De Vincentis. PNPLA3 allele frequency has no impact on biliary bile acid composition or disease course in patients with primary sclerosing cholangitis. PLOS ONE 2022; 17(12): e0277084 doi: 10.1371/journal.pone.0277084
104
Long Zhang, Wei You, Hanze Zhang, Rui Peng, Qin Zhu, Aihua Yao, Xiangcheng Li, Yebin Zhou, Xuehao Wang, Liyong Pu, Jindao Wu. PNPLA3 polymorphisms (rs738409) and non‐alcoholic fatty liver disease risk and related phenotypes: a meta‐analysis. Journal of Gastroenterology and Hepatology 2015; 30(5): 821 doi: 10.1111/jgh.12889
105
Grace Teskey, Nivedita Tiwari, Andrew J. Butcko, Amit Kumar, Anuradha Yadav, Yu-ming M. Huang, Christopher V. Kelly, James G. Granneman, James W. Perfield, Emilio P. Mottillo. Lipid droplet targeting of the lipase coactivator ABHD5 and the fatty liver disease-causing variant PNPLA3 I148M is required to promote liver steatosis. Journal of Biological Chemistry 2025; 301(2): 108186 doi: 10.1016/j.jbc.2025.108186
106
Marica Meroni, Paola Dongiovanni, Miriam Longo, Fabrizia Carli, Guido Baselli, Raffaela Rametta, Serena Pelusi, Sara Badiali, Marco Maggioni, Melania Gaggini, Anna Ludovica Fracanzani, Stefano Romeo, Stefano Gatti, Nicholas O. Davidson, Amalia Gastaldelli, Luca Valenti. Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes. EBioMedicine 2020; 52: 102658 doi: 10.1016/j.ebiom.2020.102658
107
Tyler J Severson, Siddesh Besur, Herbert L Bonkovsky. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review. World Journal of Gastroenterology 2016; 22(29): 6742-6756 doi: 10.3748/wjg.v22.i29.6742
108
Keyur Patel, Nicholas A. Shackel. Current status of fibrosis markers. Current Opinion in Gastroenterology 2014; 30(3): 253 doi: 10.1097/MOG.0000000000000059
109
Giuseppina Umano, Mariangela Martino, Nicola Santoro. The Association between Pediatric NAFLD and Common Genetic Variants. Children 2017; 4(6): 49 doi: 10.3390/children4060049
110
Lorne J. Hofseth, Ainsley Weston, Curtis C. Harris. Holland‐Frei Cancer Medicine. 2022; : 1 doi: 10.1002/9781119000822.hfcm023.pub2
111
Joseph A. Akambase, Jhon E. Prieto, Angelo Z. Mattos, Angelo A. Mattos, Enrique Carrera, Javier Díaz‐Ferrer, Patricia Gallardo, Andrea Curia, Esteban G. Ballerga, Cristiane V. Tovo, Domingo Balderramo, Jose D. Debes. Epidemiology and risk factors for histopathologic characteristics of non‐alcoholic fatty liver disease in South America. Alimentary Pharmacology & Therapeutics 2023; 58(5): 526 doi: 10.1111/apt.17615
112
Zelin Tian, Chen Xu, Peijun Yang, Zhibin Lin, Wenlong Wu, Wenjie Zhang, Jian Ding, Rui Ding, Xuan Zhang, Kefeng Dou. Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.984728
113
Alexander Yang, Emilio P. Mottillo. Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics. Biochemical Journal 2020; 477(5): 985 doi: 10.1042/BCJ20190468
114
Luca Valenti, Serena Pelusi. Non-Alcoholic Fatty Liver Disease. 2020; : 129 doi: 10.1007/978-3-319-95828-6_7
115
Konstantinos Arvanitakis, Theocharis Koufakis, Kalliopi Kotsa, Georgios Germanidis. The effects of sodium-glucose cotransporter 2 inhibitors on hepatocellular carcinoma: From molecular mechanisms to potential clinical implications. Pharmacological Research 2022; 181: 106261 doi: 10.1016/j.phrs.2022.106261
116
Eleonora Dileo, Francesca Saba, Mirko Parasiliti-Caprino, Chiara Rosso, Elisabetta Bugianesi. Impact of Sexual Dimorphism on Therapy Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: From Conventional and Nutritional Approaches to Emerging Therapies. Nutrients 2025; 17(3): 477 doi: 10.3390/nu17030477
117
Somaya Albhaisi, Arun J. Sanyal. Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.665987
118
Joseph Asemota, Olubunmi Oladunjoye, Atinuke Babalola, Ugonna Nwosu, Po-Hong S Liu, Adeolu O Oladunjoye, Nelsy Castro-Webb, Rebecca A Miksad. Comparison of Hepatocellular Carcinoma in Hispanics and Non-Hispanics Patients. Cureus 2021;  doi: 10.7759/cureus.14884
119
Patrick Borel, Charles Desmarchelier. Genetic Variations Associated with Vitamin A Status and Vitamin A Bioavailability. Nutrients 2017; 9(3): 246 doi: 10.3390/nu9030246
120
Ainura Amirkulova, Gulmira Derbissalina, Valeriy Benberin, Nasrulla Shanazarov, Gulshara Abildinova, Doskhan Kozhakhmet, Helena Katchman. Association between PNPLA3 and TM6SF2 gene polymorphisms and non-alcoholic fatty liver disease patients in Kazakhstan. Electronic Journal of General Medicine 2023; 20(6): em546 doi: 10.29333/ejgm/13718
121
Olivier Govaere, Quentin M. Anstee. Encyclopedia of Cell Biology. 2023; : 610 doi: 10.1016/B978-0-12-821618-7.00265-0
122
Alice Marmugi, Céline Lukowicz, Frederic Lasserre, Alexandra Montagner, Arnaud Polizzi, Simon Ducheix, Adeline Goron, Laurence Gamet-Payrastre, Sabine Gerbal-Chaloin, Jean Marc Pascussi, Marthe Moldes, Thierry Pineau, Hervé Guillou, Laila Mselli-Lakhal. Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way. Toxicology and Applied Pharmacology 2016; 303: 90 doi: 10.1016/j.taap.2016.05.006
123
Ludovico Abenavoli. Alcoholic Liver Disease: From Bench to Bedside. Reviews on Recent Clinical Trials 2019; 14(3): 158 doi: 10.2174/157488711403190718125454
124
Georgiana-Emmanuela Gîlcă-Blanariu, Daniela Simona Budur, Dana Elena Mitrică, Elena Gologan, Oana Timofte, Gheorghe Gh Bălan, Vasile Andrei Olteanu, Gabriela Ștefănescu. Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease. Metabolites 2023; 13(11): 1115 doi: 10.3390/metabo13111115
125
Annalisa Cespiati, Felice Cinque, Marica Meroni, Rosa Lombardi, Paola Dongiovanni, Anna Ludovica Fracanzani. An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians. Biomedicines 2023; 11(2): 586 doi: 10.3390/biomedicines11020586
126
Azam Moslehi, Zeinab Hamidi-zad. Role of SREBPs in Liver Diseases: A Mini-review. Journal of Clinical and Translational Hepatology 2018; 6(3): 1 doi: 10.14218/JCTH.2017.00061
127
Massimiliano Ruscica, Nicola Ferri, Chiara Macchi, Marica Meroni, Claudia Lanti, Chiara Ricci, Marco Maggioni, Anna Ludovica Fracanzani, Sara Badiali, Silvia Fargion, Paolo Magni, Luca Valenti, Paola Dongiovanni. Liver fat accumulation is associated with circulating PCSK9. Annals of Medicine 2016; 48(5): 384 doi: 10.1080/07853890.2016.1188328
128
William S. Blaner. Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders. Pharmacology & Therapeutics 2019; 197: 153 doi: 10.1016/j.pharmthera.2019.01.006
129
Luca Valenti, Elisabetta Bugianesi, Utpal Pajvani, Giovanni Targher. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?. Liver International 2016; 36(11): 1563 doi: 10.1111/liv.13185
130
Luigi Boccuto, Andrew Mitz, Ludovico Abenavoli, Sara M. Sarasua, William Bennett, Curtis Rogers, Barbara DuPont, Katy Phelan. Phenotypic Variability in Phelan–McDermid Syndrome and Its Putative Link to Environmental Factors. Genes 2022; 13(3): 528 doi: 10.3390/genes13030528
131
S Pillai, S Duvvuru, P Bhatnagar, W Foster, M Farmen, S Shankar, C Harris, E Bastyr, B Hoogwerf, A Haupt. The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro. The Pharmacogenomics Journal 2018; 18(3): 487 doi: 10.1038/tpj.2017.45
132
Meng-Yuan Wu, Jian-Gao Fan. Gut microbiome and nonalcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International 2023; 22(5): 444 doi: 10.1016/j.hbpd.2023.06.006
133
Stefano Romeo, Arun Sanyal, Luca Valenti. Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease. Cell Metabolism 2020; 31(1): 35 doi: 10.1016/j.cmet.2019.12.002
134
Federico Salomone, Justyna Godos, Shira Zelber‐Sagi. Natural antioxidants for non‐alcoholic fatty liver disease: molecular targets and clinical perspectives. Liver International 2016; 36(1): 5 doi: 10.1111/liv.12975
135
Hisamitsu Miyaaki, Kazuhiko Nakao. Significance of genetic polymorphisms in patients with nonalcoholic fatty liver disease. Clinical Journal of Gastroenterology 2017; 10(3): 201 doi: 10.1007/s12328-017-0732-5
136
Paola Dongiovanni, Stefano Romeo, Luca Valenti. Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/460190
137
Ozlem Kutlu, Humeyra Nur Kaleli, Ebru Ozer. Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/8543763
138
Shuhua Yuan, Hongxia Liu, Ding Yuan, Jing Xu, Yunzhi Chen, Xiao Xu, Fen Xu, Hua Liang. PNPLA3 I148M mediates the regulatory effect of NF‐kB on inflammation in PA‐treated HepG2 cells. Journal of Cellular and Molecular Medicine 2020; 24(2): 1541 doi: 10.1111/jcmm.14839
139
Paola Dongiovanni, Jussi Pihlajamaki, Stefano Romeo, Luca Valenti. Reply to “Statin treatment for non-alcoholic steatohepatitis”. Journal of Hepatology 2016; 64(1): 242 doi: 10.1016/j.jhep.2015.09.023
140
Piero Portincasa, Mohamad Khalil, Laura Mahdi, Valeria Perniola, Valeria Idone, Annarita Graziani, Gyorgy Baffy, Agostino Di Ciaula. Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options. International Journal of Molecular Sciences 2024; 25(11): 5640 doi: 10.3390/ijms25115640
141
Vincenzo Ronca, Alessio Gerussi, Paul Collins, Alessandro Parente, Ye Htun Oo, Pietro Invernizzi. The liver as a central “hub” of the immune system: pathophysiological implications. Physiological Reviews 2025; 105(2): 493 doi: 10.1152/physrev.00004.2023
142
Alice Emma Taliento, Marcello Dallio, Alessandro Federico, Daniele Prati, Luca Valenti. Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease. International Journal of Environmental Research and Public Health 2019; 16(15): 2755 doi: 10.3390/ijerph16152755
143
Jose Altamirano, Eric S. Orman, Ramon Bataller. Yamada' s Textbook of Gastroenterology. 2015; : 2043 doi: 10.1002/9781118512074.ch103
144
Hisamitsu Miyaaki, Satoshi Miuma, Naota Taura, Hidetaka Shibata, Ryu Sasaki, Akihiko Soyama, Masaaki Hidaka, Mitsuhisa Takatsuki, Susumu Eguchi, Kazuhiko Nakao. Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver Transplantation. Transplantation 2019; 103(1): 109 doi: 10.1097/TP.0000000000002319
145
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani. Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC. Biomedicines 2021; 9(11): 1524 doi: 10.3390/biomedicines9111524
146
Felice Cinque, Annalisa Cespiati, Rosa Lombardi, Andrea Costantino, Gabriele Maffi, Francesca Alletto, Lucia Colavolpe, Paolo Francione, Giovanna Oberti, Erika Fatta, Cristina Bertelli, Giordano Sigon, Paola Dongiovanni, Maurizio Vecchi, Silvia Fargion, Anna Ludovica Fracanzani. Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown. Nutrients 2022; 14(3): 556 doi: 10.3390/nu14030556
147
Haider Ghazanfar, Nismat Javed, Abeer Qasim, George Sarin Zacharia, Ali Ghazanfar, Abhilasha Jyala, Elona Shehi, Harish Patel. Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review. Cancers 2024; 16(6): 1214 doi: 10.3390/cancers16061214
148
Luigi Boccuto, Ludovico Abenavoli. The impact of genetic polymorphisms on liver diseases: entering the era of personalized medicine. European Journal of Gastroenterology & Hepatology 2017; 29(9): 1102 doi: 10.1097/MEG.0000000000000917
149
Simona Riccio, Rosa Melone, Caterina Vitulano, Pierfrancesco Guida, Ivan Maddaluno, Stefano Guarino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics. World Journal of Clinical Pediatrics 2022; 11(3): 221-238 doi: 10.5409/wjcp.v11.i3.221
150
Eriks Smagris, Soumik BasuRay, John Li, Yongcheng Huang, Ka‐man V. Lai, Jesper Gromada, Jonathan C. Cohen, Helen H. Hobbs. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology 2015; 61(1): 108 doi: 10.1002/hep.27242
151
Yuli Sun, Zhaofeng Tan, Zhenyuan Jiang, Min Li, Weiqin Wang, Yaoyao Huang, Jianguang Sun. Comparative efficacy and safety of traditional Chinese patent medicine for NAFLD in childhood or adolescence. Medicine 2021; 100(3): e24277 doi: 10.1097/MD.0000000000024277
152
P. Wainwright, E. Scorletti, C. D. Byrne. Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis. Current Diabetes Reports 2017; 17(4) doi: 10.1007/s11892-017-0851-x
153
Francesca Lanzaro, Stefano Guarino, Elisabetta D'Addio, Alessandra Salvatori, Josè Alberto D'Anna, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Metabolic-associated fatty liver disease from childhood to adulthood: State of art and future directions. World Journal of Hepatology 2022; 14(6): 1087-1098 doi: 10.4254/wjh.v14.i6.1087
154
Pierre Bedossa, Keyur Patel. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease. Gastroenterology 2016; 150(8): 1811 doi: 10.1053/j.gastro.2016.03.008
155
Luigi Boccuto, Ludovico Abenavoli. Genetic and Epigenetic Profile of Patients With Alcoholic Liver Disease. Annals of Hepatology 2017; 16(4): 490 doi: 10.5604/01.3001.0010.0274
156
Claudia Maccali, Isabel V. A. Pereira, José Tadeu Stefano, Claudia P. Oliveira. Risk of Liver Cancer in MASLD: Role of Genetic Risk Scores. Current Hepatology Reports 2023; 22(4): 228 doi: 10.1007/s11901-023-00623-6
157
Ignacio Novo-Veleiro, Lucía Alvela-Suárez, Antonio-Javier Chamorro, Rogelio González-Sarmiento, Francisco-Javier Laso, Miguel Marcos. Alcoholic liver disease and hepatitis C virus infection. World Journal of Gastroenterology 2016; 22(4): 1411-1420 doi: 10.3748/wjg.v22.i4.1411
158
Bubu A. Banini, Divya P. Kumar, Sophie Cazanave, Mulugeta Seneshaw, Faridoddin Mirshahi, Prasanna K. Santhekadur, Liangsu Wang, Hong Ping Guan, Abdul M. Oseini, Cristina Alonso, Pierre Bedossa, Srinivas V. Koduru, Hae‐Ki Min, Arun J. Sanyal. Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin‐Like Phospholipase Domain Containing 3–Mediated Acceleration of Steatohepatitis. Hepatology 2021; 73(4): 1290 doi: 10.1002/hep.31609
159
Alexander Yang, Emilio P. Mottillo, Ljiljana Mladenovic-Lucas, Li Zhou, James G. Granneman. Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytes. Nature Metabolism 2019; 1(5): 560 doi: 10.1038/s42255-019-0066-3
160
Pierluigi Marzuillo, Anna Grandone, Laura Perrone, Emanuele Miraglia del Giudice. Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics. World Journal of Hepatology 2015; 7(11): 1439-1443 doi: 10.4254/wjh.v7.i11.1439
161
Sean W.P. Koppe. Obesity and the liver: nonalcoholic fatty liver disease. Translational Research 2014; 164(4): 312 doi: 10.1016/j.trsl.2014.06.008
162
Rosa Lombardi, Lucia Colavolpe, Francesca Alletto, Annalisa Cespiati, Erika Fatta, Cristina Bertelli, Felice Cinque, Giuseppina Pisano, Edoardo Pulixi, Paolo Francione, Gabriele Maffi, Federica Iuculano, Paola Dongiovanni, Marica Meroni, Larry Burdick, Daniela Bignamini, Marco Maggioni, Luca Valenti, Silvia Fargion, Anna Ludovica Fracanzani. Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades. Digestive and Liver Disease 2024; 56(1): 144 doi: 10.1016/j.dld.2023.07.009
163
Rosellina Margherita Mancina, Rocco Spagnuolo, Marta Milano, Simona Brogneri, Attilio Morrone, Cristina Cosco, Veronica Lazzaro, Cristina Russo, Yvelise Ferro, Piero Pingitore, Arturo Pujia, Tiziana Montalcini, Patrizia Doldo, Pietro Garieri, Luca Piodi, Flavio Caprioli, Luca Valenti, Stefano Romeo. PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes. Inflammatory Bowel Diseases 2016; 22(1): 134 doi: 10.1097/MIB.0000000000000569
164
Vittoria Moretti, Stefano Romeo, Luca Valenti. The contribution of genetics and epigenetics to MAFLD susceptibility. Hepatology International 2024; 18(S2): 848 doi: 10.1007/s12072-024-10667-5
165
Lorne J. Hofseth, Ainsley Weston, Curtis C. Harris. Holland‐Frei Cancer Medicine. 2017; : 1 doi: 10.1002/9781119000822.hfcm023
166
Hyeyoung Kim, Kwang‐Woong Lee, Kyoungbun Lee, Sooin Seo, Min‐Young Park, Sung Woo Ahn, Suk Kyun Hong, Kyung Chul Yoon, Hyo‐Sin Kim, YoungRok Choi, Hae Won Lee, Nam‐Joon Yi, Kyung‐Suk Suh. Effect of PNPLA3 I148M polymorphism on histologically proven non‐alcoholic fatty liver disease in liver transplant recipients. Hepatology Research 2018; 48(3) doi: 10.1111/hepr.12940
167
Luca Valenti, Stefano Romeo. Destined to develop NAFLD? The predictors of fatty liver from birth to adulthood. Journal of Hepatology 2016; 65(4): 668 doi: 10.1016/j.jhep.2016.06.010
168
Sasanka Ramanadham, Tomader Ali, Jason W. Ashley, Robert N. Bone, William D. Hancock, Xiaoyong Lei. Calcium-independent phospholipases A2 and their roles in biological processes and diseases. Journal of Lipid Research 2015; 56(9): 1643 doi: 10.1194/jlr.R058701
169
Eleonora Scorletti, Annette L. West, Lokpal Bhatia, Samuel P. Hoile, Keith G. McCormick, Graham C. Burdge, Karen A. Lillycrop, Geraldine F. Clough, Philip C. Calder, Christopher D. Byrne. Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial. Journal of Hepatology 2015; 63(6): 1476 doi: 10.1016/j.jhep.2015.07.036
170
Rotonya M. Carr, Rexford S. Ahima. Pathophysiology of lipid droplet proteins in liver diseases. Experimental Cell Research 2016; 340(2): 187 doi: 10.1016/j.yexcr.2015.10.021
171
Piero Pingitore, Stefano Romeo. The role of PNPLA3 in health and disease. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019; 1864(6): 900 doi: 10.1016/j.bbalip.2018.06.018
172
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Maria Vittoria Morone, Chiara Silvestri, Mauro Giordano, Teresa Salvatore, Ferdinando Carlo Sasso. Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review. Antioxidants 2021; 10(2): 270 doi: 10.3390/antiox10020270
173
Annalisa Crudele, Nadia Panera, Maria Rita Braghini, Clara Balsano, Anna Alisi. The pharmacological treatment of nonalcoholic fatty liver disease in children. Expert Review of Clinical Pharmacology 2020; 13(11): 1219 doi: 10.1080/17512433.2020.1829468
174
Jun Luo, Zhongshan Lu, Zibiao Zhong, Meichen Pi, Yan Xiong, Ling Li, Ting Chen, Yiwen Chen, Cong-Yi Wang, Zhongzhong Liu, Qifa Ye. ALDH2 deficiency exacerbates MCD-diet induced MASLD by modulating bile acid metabolism. Free Radical Biology and Medicine 2024; 212: 34 doi: 10.1016/j.freeradbiomed.2023.12.017
175
Yoshitaka Sakurai, Naoto Kubota, Toshimasa Yamauchi, Takashi Kadowaki. Role of Insulin Resistance in MAFLD. International Journal of Molecular Sciences 2021; 22(8): 4156 doi: 10.3390/ijms22084156
176
Joost Boeckmans, Alexandra Gatzios, Jörn M. Schattenberg, Ger H. Koek, Robim M. Rodrigues, Tamara Vanhaecke. PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review. Liver International 2023; 43(5): 975 doi: 10.1111/liv.15533
177
Jincheng Wang, Tao Qin, Jinyu Sun, Shiwu Li, Lihua Cao, Xiaojie Lu. Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.1046497
178
Kalliopi Azariadis, Nikolaos K. Gatselis, Aggeliki Lyberopoulou, Pinelopi Arvaniti, Kalliopi Zachou, Stella Gabeta, George N. Dalekos. PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortality. Journal of Translational Autoimmunity 2024; 9: 100243 doi: 10.1016/j.jtauto.2024.100243
179
Sara Arefhosseini, Mehrangiz Ebrahimi-Mameghani, Farzad Najafipour, Helda Tutunchi. Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032361
180
Dorothy A. Kieffer, Valentina Medici. Wilson disease: At the crossroads between genetics and epigenetics—A review of the evidence. Liver Research 2017; 1(2): 121 doi: 10.1016/j.livres.2017.08.003
181
Marica Meroni, Miriam Longo, Alice Rustichelli, Paola Dongiovanni. Nutrition and Genetics in NAFLD: The Perfect Binomium. International Journal of Molecular Sciences 2020; 21(8): 2986 doi: 10.3390/ijms21082986
182
Marica Meroni, Miriam Longo, Paola Dongiovanni. Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease. Exploration of Medicine 2020; 1(4): 218 doi: 10.37349/emed.2020.00015
183
Luca Valenti, Paola Dongiovanni. Mutant PNPLA3 I148M protein as pharmacological target for liver disease. Hepatology 2017; 66(4): 1026 doi: 10.1002/hep.29298
184
Salvatore Petta, Luca Valenti, Elisabetta Bugianesi, Giovanni Targher, Stefano Bellentani, Ferruccio Bonino, Ele Ferrannini, Carmela Loguercio, Amedeo Lonardo, Fabio Marra, Marcello Mancini, Luca Miele, Valerio Nobili, Gianluca Svegliati Baroni, Federico Alessandro, Stefano Ballestri, Maurizia Rossana Brunetto, Barbara Coco, Antonio Grieco, Silvia Fargion, Loreta Kondili, Fabio Nascimbeni, Anna Prinster, Dante Romagnoli, Stefano Taddei, Ester Vanni, Stefano Vella. A “systems medicine” approach to the study of non-alcoholic fatty liver disease. Digestive and Liver Disease 2016; 48(3): 333 doi: 10.1016/j.dld.2015.10.027
185
Michele Nardolillo, Fabiola Rescigno, Mario Bartiromo, Dario Piatto, Stefano Guarino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Interplay between metabolic dysfunction-associated fatty liver disease and renal function: An intriguing pediatric perspective. World Journal of Gastroenterology 2024; 30(15): 2081-2086 doi: 10.3748/wjg.v30.i15.2081
186
Mirella Pastore, Alessandra Gentilini, Fabio Marra. Non-Alcoholic Fatty Liver Disease. 2020; : 97 doi: 10.1007/978-3-319-95828-6_6
187
Rotonya M. Carr, Jason Correnti. Insulin resistance in clinical and experimental alcoholic liver disease. Annals of the New York Academy of Sciences 2015; 1353(1): 1 doi: 10.1111/nyas.12787
188
Hilmar K Lückhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
189
Paola Dongiovanni, Luca Valenti. A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2017; 18(7): 1534 doi: 10.3390/ijms18071534
190
Stephen A. Harrison. Nonalcoholic Fatty Liver Disease and Fibrosis Progression: The Good, the Bad, and the Unknown. Clinical Gastroenterology and Hepatology 2015; 13(4): 655 doi: 10.1016/j.cgh.2014.11.024
191
Pierre Bedossa, David E. Kleiner. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; : 223 doi: 10.1007/978-3-319-20538-0_12
192
Joost Willebrords, Isabel Veloso Alves Pereira, Michaël Maes, Sara Crespo Yanguas, Isabelle Colle, Bert Van Den Bossche, Tereza Cristina Da Silva, Cláudia Pinto Marques Souza de Oliveira, Wellington Andraus, Venâncio Avancini Alves, Bruno Cogliati, Mathieu Vinken. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Progress in Lipid Research 2015; 59: 106 doi: 10.1016/j.plipres.2015.05.002
193
Alison Mondul, Rosellina M Mancina, Andrea Merlo, Paola Dongiovanni, Raffaela Rametta, Tiziana Montalcini, Luca Valenti, Demetrius Albanes, Stefano Romeo. PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity ,. The Journal of Nutrition 2015; 145(8): 1687 doi: 10.3945/jn.115.210633
194
Carolyn Vespoli, Anoop Mohamed Iqbal, Mohammad Nasser Kabbany, Kadakkal Radhakrishnan. Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence. Endocrinology and Metabolism Clinics of North America 2023; 52(3): 417 doi: 10.1016/j.ecl.2023.02.001
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345